Author: Latika Gupta; Durga Misra; Vishwesh Agarwal; Suma Balan; Vikas Agarwal
Title: Management of rheumatic diseases in the times of COVID-19 pandemic- perspectives of rheumatology practitioners from India Document date: 2020_4_7
ID: 2kkw9nwa_49
Snippet: Hydroxychloroquine (HCQ) was the preferred choice for treatment (81.9% respondents) followed by protease inhibitors (22.17%) and IVIG (8.14%). Chloroquine was less popular (19%). 22.6% felt that HCQ prophylaxis might work for COVID-19, and the same number prescribed prophylaxis to their patients, while 27.15% were not sure if it would be beneficial......
Document: Hydroxychloroquine (HCQ) was the preferred choice for treatment (81.9% respondents) followed by protease inhibitors (22.17%) and IVIG (8.14%). Chloroquine was less popular (19%). 22.6% felt that HCQ prophylaxis might work for COVID-19, and the same number prescribed prophylaxis to their patients, while 27.15% were not sure if it would be beneficial.
Search related documents:
Co phrase search for related documents- preferred choice and treatment preferred choice: 1, 2, 3, 4, 5, 6, 7, 8, 9
Co phrase search for related documents, hyperlinks ordered by date